ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #7,442Hybrid

Archivum Immunologiae et Therapiae Experimentalis

Acronym:aite
•
Abbreviation (ISO):ARCH IMMUNOL THER EX
•
Identifier (ISSN):0004-069X(Print)/1661-4917(Online)
•
Publisher:Springer International Publishing
Clarivate IF (2026)
3.2↓ -0.7
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Archivum Immunologiae et Therapiae Experimentalis

WoS Q3
23563.0220182.8820193.220204.2920213.8320223.220232.920243.920253.22026
Annual Impact Factor Metric
Current (2026):3.2
Scopus SJR & RankScopus Q2
0.759
#7,442

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
79

79 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate3.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
31articles/year
87.32% Gold OA•61.54% Original Research

Aims & Scope

Archivum Immunologiae et Therapiae Experimentalis (AITE), founded in 1953 by Ludwik Hirszfeld, is a bimonthly, multidisciplinary journal. It publishes reviews and full original papers dealing with immunology, experimental therapy, immunogenetics, transplantation, microbiology, immunochemistry and ethics in science.

Topics Covered (Recognized by AI)
Biology96.6%Medicine90%Genetics83.6%Chemistry76.9%Immunology70.5%Biochemistry67.7%Internal medicine66.3%Pathology30.6%Endocrinology29.2%Immune system28.9%Antibody28.1%Gene25.9%Antigen25%Organic chemistry25%Physics22.4%In vitro22.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q3
Rank103/183
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q3
Rank127/183
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.2
Articles / Year15
Total Citations1
2025
IF3.9
Articles / Year31
Total Citations52
2024
IF2.9
Articles / Year25
Total Citations440
2023
IF3.2
Articles / Year23
Total Citations311
2022
IF3.831
Articles / Year27
Total Citations317

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,442Scopus Q2SCImago Profile
Scopus Coverage:1954-1957, 1959-1977, 1979-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q2
0.759

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.49

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,196 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations246
3-Year Documents75
Citable Documents74

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate58.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2
ImmunologyQ3
Immunology and AllergyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Archivum Immunologiae et Therapiae Experimentalis (acronym: aite, abbr: ARCH IMMUNOL THER EX, ISSN: 0004-069X) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer International Publishing in Poland since 2006. The periodical holds a Journal Impact Factor (JIF) of 3.20, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.759 (Q2), an H-index of 79.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 31 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,196 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer International Publishing
Publication Language
English
Frequency
Bimonthly
Founding Year
2006
Indexing & Databases
SCIEScopusPubMed
Editorial Address
BIRKHAUSER VERLAG AG, VIADUKSTRASSE 40-44, PO BOX 133, BASEL, SWITZERLAND, CH-4010

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: c51fc3ac-9b18-4475-87d9-2654778de20b
Database Updated: 2026-10-01